Shortened protocol in practical [11C]SA4503-PET studies for sigma1 receptor quantification

Annals of Nuclear Medicine

Volumn 22, Issue 2, 2008, Pages 143-146

  Sakata, Muneyuki ^a,b   Kimura, Yuichi ^a,c   Naganawa, Mika ^c,d   Ishikawa, Masatomo ^a,e   Oda, Keiichi ^a   Ishii, Kenji ^a   Hashimoto, Kenji ^e   Chihara, Kunihiro ^b   Ishiwata, Kiichi ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^d JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^e CHIBA UNIVERSITY   (Japan)

Author keywords

Kinetic; PET; Sigma1 receptor; 11C SA4503

Indexed keywords

1 (3,4 DIMETHOXYPHENETHYL) 4 (3 PHENYLPROPYL)PIPERAZINE; 1 (3,4 DIMETHOXYPHENETHYL) 4 (3 PHENYLPROPYL)PIPERAZINE C 11; CARBON 11; FLUVOXAMINE; HALOPERIDOL; RADIOISOTOPE; RADIOLIGAND; SEROTONIN UPTAKE INHIBITOR; SIGMA 1 OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING KINETICS; BRAIN DISEASE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISTRIBUTION VOLUME; DRUG RECEPTOR BINDING; HUMAN; HUMAN EXPERIMENT; MALE; MEASUREMENT; NORMAL HUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR OCCUPANCY;

EID: 40149103639     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-007-0088-x     Document Type: Article

References (8)

1. 1. K. Kawamura K. Ishiwata H. Tajima S. Ishii K. Matsuno Y. Homma 2000 In vivo evaluation of [ 11 C]SA4503 as a PET ligand for mapping CNS sigma 1 receptors Nucl Med Biol 27 255 261 10832082 10.1016/S0969-8051(00)00081-0 1:CAS:528:DC%2BD3cXjs1Cgtb0%3D Kawamura K, Ishiwata K, Tajima H, Ishii S, Matsuno K, Homma Y, et al. In vivo evaluation of [ 11 C]SA4503 as a PET ligand for mapping CNS sigma 1 receptors. Nucl Med Biol 2000;27:255–261.
2. 2. M. Sakata Y. Kimura M. Naganawa K. Oda K. Ishii K. Chihara 2007 Mapping of human cerebral sigma 1 receptors using positron emission tomography and [ 11 C]SA4503 Neuroimage 35 1 8 17240168 10.1016/j.neuroimage.2006.11.055 Sakata M, Kimura Y, Naganawa M, Oda K, Ishii K, Chihara K, et al. Mapping of human cerebral sigma 1 receptors using positron emission tomography and [ 11 C]SA4503. Neuroimage 2007;35:1–8.
3. 3. M. Mishina K. Ishiwata K. Ishii S. Kitamura Y. Kimura K. Kawamura 2005 Function of sigma 1 receptors in Parkinson’s disease Acta Neurol Scand 112 103 107 16008536 10.1111/j.1600-0404.2005.00432.x 1:CAS:528:DC%2BD2MXos1Crtbc%3D Mishina M, Ishiwata K, Ishii K, Kitamura S, Kimura Y, Kawamura K, et al. Function of sigma 1 receptors in Parkinson’s disease. Acta Neurol Scand 2005;112:103–107.
4. 4. K. Ishiwata K. Oda M. Sakata Y. Kimura K. Kawamura K. Oda 2006 A feasible study of [ 11 C]SA4503-PET for evaluating sigma 1 receptor occupancy by neuroleptics: the binding of haloperidol to sigma1 and dopamine D 2-like receptors Ann Nucl Med 20 569 573 17134027 1:CAS:528:DC%2BD2sXkvFOqtw%3D%3D 10.1007/BF03026824 Ishiwata K, Oda K, Sakata M, Kimura Y, Kawamura K, Oda K, et al. A feasible study of [ 11 C]SA4503-PET for evaluating sigma 1 receptor occupancy by neuroleptics: the binding of haloperidol to sigma1 and dopamine D 2-like receptors. Ann Nucl Med 2006;20:569–573.
5. 5. H. Watabe Y. Ikoma Y. Kimura M. Naganawa M. Shidahara 2006 PET kinetic analysis: compartmental model Ann Nucl Med 20 583 588 17294668 1:CAS:528:DC%2BD2sXhvFyktr4%3D Watabe H, Ikoma Y, Kimura Y, Naganawa M, Shidahara M. PET kinetic analysis: compartmental model. Ann Nucl Med 2006;20:583–588.
6. 6. J. Logan J.S. Fower N.D. Volkow A.P. Wolf S.L. Dewey D.J. Schlyer 1990 Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11 C-methyl]-(−)-cocaine PET studies in human subjects J Cereb Blood Flow Metab 10 740 747 2384545 1:CAS:528:DyaK3cXmtVOmu7Y%3D Logan J, Fower JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11 C-methyl]-(−)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 1990;10:740–747.
7. 7. Y. Kimura M. Naganawa M. Sakata M. Ishikawa M. Mishina K. Oda 2007 Distribution volume as an alternative to the binding potential for sigma 1 receptor imaging Ann Nucl Med 21 533 535 18030587 10.1007/s12149-007-0063-6 Kimura Y, Naganawa M, Sakata M, Ishikawa M, Mishina M, Oda K, et al. Distribution volume as an alternative to the binding potential for sigma 1 receptor imaging, Ann Nucl Med 2007;21:533–535.
8. 8. M. Ishikawa K. Ishiwata K. Ishii Y. Kimura M. Sakata M. Naganawa 2007 High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a PET study using [ 11 C]SA4503 Biol Psychiatry 62 878 883 17662961 10.1016/j.biopsych.2007.04.001 1:CAS:528:DC%2BD2sXhtFerur3K Ishikawa M, Ishiwata K, Ishii K, Kimura Y, Sakata M, Naganawa M, et al. High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a PET study using [ 11 C]SA4503. Biol Psychiatry 2007;62:878–883.